Preclinical PTSD Working Group Meeting
December 16, 2015Read moreCohen Veterans Bioscience held its first Preclinical PTSD Working Group meeting in Hollywood, Florida on December 5, 2015. This event was co-chaired by Dr. Kerry Ressler, Chief Scientific Officer at McLean Hospital and Professor of Psychiatry at Harvard Medical School, and Dr. Magali Haas, CEO of Cohen Veterans Bioscience. The Cohen Veterans Bioscience Preclinical Working Group is designed to bring together world-leading clinical researchers and preclinical scientists from academia and industry with the goal of informing Cohen Veterans Bioscience’s preclinical development strategy.
Cohen Veterans Bioscience Open House at ISTSS
November 16, 2015Read moreCohen Veterans Bioscience attended the International Society for Traumatic Stress Studies (ISTSS) conference in New Orleans from November 4-7, 2015.
CNS Summit 2015 – October 8-11, 2015
October 23, 2015Read moreCohen Veterans Bioscience CEO & President, Dr. Magali Haas, participated in the CNS Summit 2015, which convened from October 8-11 in Boca Raton, Florida. There, Dr. Haas lent her extensive expertise in pharmaceutical strategy, clinical research, and biotechnology to the Keynote Session, “What Will be the Impact of Silicon Valley on Drug Development?”
MassBio Nonprofit Leaders Roundtable
August 26, 2015Read moreSeptember 17, 2015
Please join CEO Magali Haas at the upcoming Mass Bio event on the diverse landscape of Bio-pharma Non-profits in Massachusetts on September 17.
Molecular Medicine Tri-Conference | February 15-20, 2015 | San Francisco, CA
February 1, 2015Read moreThe 22nd International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 17 conference programs.
Events
